Surprisingly, we not only observed their enrichment in a variety of solid carcinomas, such as bladder cancer, non-small cell lung cancer, and PAAD but also revealed their enrichment in important tumour signalling axes, such as the PI3K-Akt and focal adhesion signalling pathways. This evidence concerns the gene AKT1 and urinary bladder carcinoma.